subscribeSubscribe
Prinston Pharma`s Generic Tofacitinib Receives Tentative Approval in U.S

Prinston Pharma`s Generic Tofacitinib Receives Tentative Approval in U.S

FDA
09 Apr 2024
Share Share
Teva Pharma`s Generic Tofacitinib Receives Approval in the U.S.

Teva Pharma`s Generic Tofacitinib Receives Approval in the U.S.
FDA
02 Feb 2024
Share Share
Sinotherapeutics` Generic Tofacitinib Receives Approval in the U.S.

Sinotherapeutics` Generic Tofacitinib Receives Approval in the U.S.
FDA
08 Aug 2023
Share Share
Zydus Lifesciences gets USFDA nod for Tofacitinib tablets

Zydus Lifesciences gets USFDA nod for Tofacitinib tablets
CNBCTV18
22 Mar 2023
Share Share
FDA Confirms Paragraph IV Patent Litigation for Tofacitinib Tablets

FDA Confirms Paragraph IV Patent Litigation for Tofacitinib Tablets
FDA
21 Mar 2023
Share Share
Zydus` Generic Tofacitinib Citrate Receives Approval in the U.S.

Zydus` Generic Tofacitinib Citrate Receives Approval in the U.S.
FDA
14 Mar 2023
Share Share
Vyne swings behind BET, seeks partner for failed eczema drug

Vyne swings behind BET, seeks partner for failed eczema drug
Nick Paul Taylor FIERCE BIOTECH
10 Mar 2023
Share Share
MSN`s Generic Tofacitinib Citrate Receives Approval in the U.S.

MSN`s Generic Tofacitinib Citrate Receives Approval in the U.S.
FDA
06 Jan 2023
Share Share
EMA backs restrictions on certain immune-regulating drugs

EMA backs restrictions on certain immune-regulating drugs
BIOPHARMADIVE
12 Nov 2022
Share Share
JAK inhibitors increase risk of cardiovascular problems and cancer, warns PRAC

JAK inhibitors increase risk of cardiovascular problems and cancer, warns PRAC
Catherine Eckford EUROPEANPHARMACEUTICALREVIEW
01 Nov 2022
Share Share